Add Yahoo as a preferred source to see more of our stories on Google. Consumer Reports has no relationship with any advertisers on this website. Nearly one in three American adults will experience an ...

There’s a new shingles vaccine and experts say you should get it if you’re over 50 — even if you’ve already been vaccinated. The new vaccine, called Shingrix, works far better to prevent the extremely ...

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved an ...

Merck announced that Zostavax (varicella zoster vaccine, live, attenuated) has gained an expanded indication for the prevention of herpes zoster (shingles) in individuals 50–59 years of age. This ...

Varicella zoster virus (VZV) is the virus that causes chicken pox, usually a relatively minor childhood illness. Unlike other viruses that are cleared from our bodies after infection, VZV stays in our ...

The federal government's Advisory Committee on Immunization Practices (ACIP) voted 8 to 7 today to recommend a new recombinant and adjuvanted herpes zoster vaccine (Shingrix, GlaxoSmithKline) over a ...

Zostavax is a vaccine indicated for the prevention of herpes zoster (shingles) in adults aged ≥50 years. The Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for ...

In March 2022, the In re Zostavax MDL court entered a Lone Pine order requiring plaintiffs who claimed to have developed shingles as a result of using the Zostavax vaccine to produce certain test ...

Even as Merck & Co. confronts the prospect of a tough market competitor in GlaxoSmithKline’s Shingrix, the drugmaker’s shingles vaccine Zostavax faces a growing challenge in court. Eighteen patients ...

A federal judge has allowed one of the first six bellwether cases in the Zostavax shingles vaccine multidistrict litigation against pharmaceutical giant Merck to proceed to a jury trial. U.S. District ...